Motiva Implants FDA Approved: What to Know in 2026

For years, women in the United States have heard about Motiva implants, a new generation of silicone breast implants popular across the globe. The big question has always been when they would be available here. The wait is finally over. In a landmark decision, Motiva implants are FDA approved, marking a new chapter for breast aesthetics in the U.S.

This approval is significant because it’s the first time in over a decade that the FDA has given the green light to a new silicone gel breast implant. For patients and surgeons, the news that Motiva implants are FDA approved means more choices, advanced technology, and a fresh perspective on achieving beautiful, natural looking results. Let’s dive into what this approval means for you.

The Official Green Light: Motiva’s FDA Approval Status

Yes, it’s official. In late September 2024, the U.S. Food and Drug Administration (FDA) approved two types of Motiva implants: the SmoothSilk® Ergonomix® and SmoothSilk® Round models. This approval specifically covers their use in primary breast augmentation and revision augmentation for women aged 22 and older.

This wasn’t just another approval; it was a milestone. It was the first premarket approval (PMA) for a new silicone breast implant granted by the FDA since 2013. The decision followed a thorough review of extensive clinical trial data, which showcased the implants’ impressive safety and effectiveness. A U.S. study demonstrated exceptionally low complication rates, with less than a 1% incidence of capsular contracture and implant rupture at the three year mark for primary augmentations, a figure considerably lower than some historical averages.

Decoding the Paperwork: What is PMA P230005?

When you see the code PMA P230005, think of it as the official file number for Motiva’s FDA approval. A Premarket Approval (PMA) is the most stringent type of device application required by the FDA. It’s reserved for high risk (Class III) medical devices like breast implants and demands comprehensive scientific evidence to prove safety and efficacy.

The approval of PMA P230005 means that Establishment Labs, the manufacturer, successfully completed what has been called “the most rigorous breast implant clinical trial ever performed under FDA guidelines.” This U.S. based trial involved hundreds of patients across 32 sites and had remarkably high follow up rates, providing the FDA with robust data to support its decision. So, when you hear about PMA P230005, you know the motiva implants fda approved status is backed by years of serious scientific study.

Exploring Your Choices: The Two FDA Approved Motiva Implants

Now that Motiva implants are FDA approved, two distinct types of Motiva implants are now available in the U.S. Both share the unique SmoothSilk® surface, but they are designed to achieve different aesthetic goals.

Motiva SmoothSilk® Ergonomix®

The Ergonomix® implant is truly innovative. It’s designed to look, feel, and move like natural breast tissue. The magic is in its special viscoelastic gel, which allows a round implant to dynamically adapt to your body’s position. When you stand up, it settles into a natural teardrop shape, and when you lie down, it returns to a rounder form.

This gives you the natural, sloped look of an anatomical implant without the risks associated with older textured teardrop models, like implant rotation. One patient who chose Ergonomix noted it was the “clear winner with [its] natural teardrop shape when I’d be standing up and roundness when lying down.”

Motiva SmoothSilk® Round

For women who desire a fuller upper breast and more prominent cleavage, the Motiva SmoothSilk® Round implant is an excellent choice. This implant maintains a consistent round shape whether you are standing or lying down, providing a perkier, “push up” look.

Like the Ergonomix, it features the advanced SmoothSilk® surface, which is bioengineered for high biocompatibility and is associated with a lower inflammatory response. This may contribute to a reduced risk of complications like capsular contracture. The Round implant uses a soft, cohesive gel to ensure you get that beautiful, full contour without the implant feeling overly firm.

Understanding the Details of the FDA Approval

The FDA provides specific guidelines, or indications, for how medical devices can be used. For Motiva, the approval comes with a few key definitions.

Augmentation Indication (Age 22+)

The motiva implants fda approved indication is for breast augmentation in women who are 22 years of age or older. This is a standard FDA regulation for all silicone gel filled breast implants used for cosmetic purposes. The age minimum helps ensure that a woman’s breasts have fully developed and that she is mature enough to make a well informed decision about the procedure.

Revision Augmentation Indication

The approval also covers revision augmentation. This is any follow up surgery to correct or improve the result of a previous breast augmentation. Women may seek revision surgery for many reasons, such as wanting to change their implant size, replace older implants, or address a complication. The fact that Motiva is approved for revisions is important, because breast implants are not considered lifetime devices, and many women will need another surgery at some point. If you’re also noticing sagging, combining implants with a breast augmentation with lift may be recommended to optimize shape and nipple position.

What’s on the Horizon: The Status of Breast Reconstruction

While the motiva implants fda approved status is a huge step forward, it is currently limited to augmentation. The use of Motiva for breast reconstruction (rebuilding the breast after a mastectomy, for example) is still considered investigational in the United States.

However, the company is actively working on this. In December 2025, Establishment Labs announced it had submitted its application to the FDA to expand the approval to include breast reconstruction. Until that is approved, patients in the U.S. can only access Motiva for reconstruction through a clinical trial.

Patient Safety First: New Labeling and Study Rules

The FDA takes patient safety and informed consent very seriously. Because Motiva implants are FDA approved under the most stringent review process, the approval comes with strict requirements for patient education and ongoing research.

Approved Labeling and Patient Information Requirements

Surgeons who offer Motiva implants must provide patients with specific FDA approved informational materials. This includes:

• A Boxed Warning: This is a clear, upfront warning that states breast implants are not lifetime devices; they are associated with a rare cancer called BIA ALCL; and some women report systemic symptoms (often called Breast Implant Illness).

• A Patient Brochure: A detailed booklet covering the risks, benefits, and what to expect from the procedure.

• A Patient Decision Checklist: A checklist that you and your surgeon must review and sign together, confirming you have discussed the key risks and considerations before surgery.

• A Patient Device Card: A card you receive after surgery that details the specifics of your implants.

These requirements empower you to make a fully informed choice. A dedicated surgeon like Dr. Leela Mundra embraces this transparency, ensuring every patient understands the process completely. For more background, you can explore our patient education videos.

Post Approval Study Requirements

Even though motiva implants fda approved status has been granted, the research doesn’t stop. The FDA has mandated a 10 year post approval study involving approximately 2,400 women to monitor long term outcomes. This study will track the incidence of rare complications, connective tissue disease symptoms, and overall patient satisfaction, ensuring the implants’ strong safety record continues to hold up over time.

How to Get Motiva Implants in the United States

Now that Motiva implants are FDA approved, they are commercially available for breast augmentation and revision in the U.S. Following the September 2024 approval, a rollout to plastic surgery practices began. Many leading surgeons, especially those involved in the clinical trials, were among the first to offer them.

Availability is steadily expanding across the country. If you are interested in exploring this new option, the best step is to find a plastic surgeon who is knowledgeable about the latest implant technologies.

For those in the Denver area, this is an exciting new option to consider for breast enhancement. At our boutique practice, we prioritize providing the most advanced and safest options for our patients. To learn if Motiva implants are right for you, we invite you to schedule a personalized consultation with Dr. Leela Mundra. Learn what to expect at a consultation so you can arrive prepared with the right questions. We are committed to a concierge experience where all your questions are answered, helping you make a choice you’ll love for years to come.

Frequently Asked Questions About FDA Approved Motiva Implants

1. So, are Motiva implants officially FDA approved?

Yes. The FDA approved Motiva SmoothSilk® Round and Ergonomix® implants in September 2024 for breast augmentation and revision in women 22 and older. The fact that Motiva implants are FDA approved is a significant development for breast aesthetics in the U.S.

2. What makes Motiva implants different from other silicone implants?

Motiva implants are known for their unique SmoothSilk® surface, which is designed to be highly biocompatible. The Ergonomix® model also features an adaptive gel that mimics the movement of natural breast tissue.

3. Are Motiva implants safer than other implants?

Clinical trial data submitted to the FDA showed very low rates of complications like capsular contracture and rupture (under 1% at three years for primary augmentations). While all surgeries have risks, this data is very promising.

4. Can I get Motiva implants for breast reconstruction after cancer?

Not for routine procedures just yet. In the U.S., the use of Motiva for breast reconstruction is still investigational, meaning it is only available through clinical trials until a separate FDA approval is granted.

5. How long do Motiva implants last?

Like all breast implants, Motiva implants are not lifetime devices. The FDA advises that the longer you have implants, the more likely it is you will need a future surgery to replace them.

Choosing to have breast surgery is a significant decision. Now that motiva implants fda approved status is a reality, you have more advanced choices than ever before. To explore all your options in a supportive and personalized environment, contact Leela Mundra MD to begin your journey.